Semaglutide is the benchmark that every new obesity drug is measured against. As the most widely prescribed GLP-1 medication worldwide, it set the standard at 14.9% average weight loss in the STEP-1 trial. Retatrutide has more than doubled that number in its Phase 3 trials. But the comparison is not as simple as picking the higher number, because semaglutide is FDA approved, widely available, and supported by years of real-world safety data. Retatrutide is none of those things yet.<\/p>\n
Semaglutide activates only the GLP-1 receptor. Retatrutide activates three. This means semaglutide’s entire effect comes from appetite suppression and delayed gastric emptying. Retatrutide adds insulin sensitization through GIP and increased energy expenditure through glucagon. The gap in efficacy is a direct consequence of the mechanism gap.<\/p>\n
Semaglutide’s STEP-1 trial: 14.9% weight loss at 68 weeks on 2.4 mg weekly. Retatrutide’s TRIUMPH-1: 28.3% at 80 weeks on 12 mg weekly. The high-BMI subgroup of TRIUMPH-1 reached 30.3% at 104 weeks. That is roughly double the weight loss of semaglutide at similar trial durations. The absolute numbers: a 250-pound person loses about 37 pounds on semaglutide and about 70 pounds on retatrutide.<\/p>\n
Semaglutide is available by prescription, covered by many insurance plans, and manufactured under cGMP standards. Retatrutide is only available through clinical trials or grey market vendors. The grey market route means no purity guarantees, no dosing accuracy assurance, and no medical oversight. For anyone who can access semaglutide through legitimate channels, the safety and reliability advantage is substantial.<\/p>\n","protected":false},"excerpt":{"rendered":"
Semaglutide is the benchmark that every new obesity drug is measured against. As the most widely prescribed GLP-1 medication worldwide, it set the standard at 14.9% average weight loss in the STEP-1 trial. Retatrutide has more than doubled that number in its Phase 3 trials. But the comparison is not as simple as picking the […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-17","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/posts\/17","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17"}],"version-history":[{"count":0,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/posts\/17\/revisions"}],"wp:attachment":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}